Skip to main content
SpringerLink
Log in

Zukunftsperspektiven in der Therapie des Typ-2-Diabetes

  • Editorial
  • Published:
Wiener Klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Referenzen

  1. Zimmet P, Shaw J, Alberti KG (2003) Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabet Med 20: 693–702 (Review)

    Article  PubMed  CAS  Google Scholar 

  2. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393–403

    Article  PubMed  CAS  Google Scholar 

  3. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Hanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343–1350

    Article  PubMed  CAS  Google Scholar 

  4. Schernthaner G (2003) Fortschritte in der Prävention des Typ-2-Diabetes. Wien Klin Wochenschr 115: 745–757

    Article  PubMed  Google Scholar 

  5. UK Prospective Diabetes Study (UKPDS) Group (1999) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 (9131): 837–853. Erratum in: Lancet 354 (9178): 602.

    Google Scholar 

  6. Stingl H, Roden M (2004) Zuküftige Angriffspunkte für die Therapie des Typ-2-Diabetes. Wien Klin Wochenschr 116: 217–229

    Article  PubMed  CAS  Google Scholar 

  7. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664–671

    Article  PubMed  CAS  Google Scholar 

  8. American Diabetes Association (2004) Standards of medical care in diabetes. Diabetes Care 27: [Suppl 1]: S15–35

    Google Scholar 

  9. Arbeitsgruppe Schweiz (2000) Gesellschaft für Endokrinologie und Diabetologie. Schweiz Ärztezeitung 81: 1403–1406

    Google Scholar 

  10. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348: 383–393

    Article  PubMed  Google Scholar 

  11. Saydah SH, Fradkin J, Cowie CC (2004) Poor control of factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291: 335–342

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Endokrinologie, Diabetologie und Klinische Ernährung, Kantonsspital Basel, Petersgraben 4, CH-4031, Basel, Schweiz

    Ulrich Keller

Authors
  1. Ulrich Keller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrich Keller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keller, U. Zukunftsperspektiven in der Therapie des Typ-2-Diabetes. Wien Klin Wochenschr 116, 213–214 (2004). https://doi.org/10.1007/BF03041049

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03041049

Key words

Search

Navigation